Dynamics Special Purpose priced its IPO of 20 million shares of Class A common stock at $10 per share.
Shares being trading today on the Nasdaq under DYNS.
The SPAC intends to focus its search for businesses across the emerging healthcare value chain, including development platforms that enable applications in prevention, diagnosis, treatment or advanced biomaterials. Specific categories include life sciences tools, enabling-software, synthetic biology and novel drug discovery.
J.P. Morgan Securities is sole book-running manager of the offering. The underwriter has a 45-day option to purchase up to an additional 3 million shares at the IPO price to cover any over-allotments. Read more.
